← Back to Clinical Trials
Recruiting NCT05136209

NCT05136209 Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05136209
Status Recruiting
Phase
Sponsor Sun Yat-sen University
Condition Congenital Cataract
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2021-11-01
Primary Completion 2026-11-01

Trial Parameters

Condition Congenital Cataract
Sponsor Sun Yat-sen University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 1 Month
Max Age 18 Years
Start Date 2021-11-01
Completion 2026-11-01
Interventions
PCCC procedure without A-vitPCCC+A-Vit procedure

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Selecting the appropriate surgical approach for congenital cataracts presents challenging for ophthalmologists. This prospective, randomized controlled study aims to compare the prognosis of posterior continuous curvilinear capsulorhexis (PCCC) with or without anterior vitrectomy (A-Vit) in treating congenital cataracts.

Eligibility Criteria

Inclusion Criteria: * Children with bilateral congenital cataracts without other ocular abnormalities * Gestational age at birth \>37 weeks * No more than 18 years old * Pupils could dilate normally pre-operation * Have signed a consent form * Can be followed Exclusion Criteria: * Intraocular pressure \>21 mmHg * History of ocular trauma and intraocular surgery

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology